RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells
- PMID: 39993193
- PMCID: PMC11892598
- DOI: 10.1073/pnas.2417308122
RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells
Abstract
Conventional dendritic cells (cDCs) are potent antigen-presenting cells (APCs) that integrate signals from their environment allowing them to direct situation-adapted immunity. Thereby they harbor great potential for being targeted in vaccination, autoimmunity, and cancer. Here, we use fate mapping, functional analyses, and comparative cross-species transcriptomics to show that RORγt+ DCs are a conserved, functionally versatile, and transcriptionally distinct type of DCs. RORγt+ DCs entail various populations described in different contexts including Janus cells/RORγt-expressing extrathymic Aire-expressing cells (eTACs), subtypes of Thetis cells, RORγt+-DC (R-DC) like cells, cDC2C and ACY3+ DCs. We show that in response to inflammatory triggers, RORγt+ DCs can migrate to lymph nodes and in the spleen can activate naïve CD4+ T cells. These findings expand the functional repertoire of RORγt+ DCs beyond the known role of eTACs and Thetis cells in inducing T cell tolerance to self-antigens and intestinal microbes in mice. We further show that RORγt+ DCs with proinflammatory features accumulate in autoimmune neuroinflammation in mice and men. Thus, our work establishes RORγt+ DCs as immune sentinel cells that exhibit a broad functional spectrum ranging from inducing peripheral T cell tolerance to T cell activation depending on signals they integrate from their environment.
Keywords: AIRE; RORγt; antigen presenting cells; dendritic cells; innate lymphocytes.
Conflict of interest statement
Competing interests statement:The authors declare no competing interest.
Figures







References
-
- Cabeza-Cabrerizo M., Cardoso A., Minutti C. M., da Costa M. P., Sousa C. R., Dendritic cells revisited. Annu. Rev. Immunol. 39, annurev-immunol-061020-053707-36 (2021). - PubMed
-
- Wculek S. K., et al. , Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7–24 (2020). - PubMed
MeSH terms
Substances
Grants and funding
- ERC-2016-STG-715182/EC | ERC | HORIZON EUROPE European Research Council (ERC)
- TRR 359 - Project number 491676693/Deutsche Forschungsgemeinschaft (DFG)
- SFB 1335/P08 - Project number 360372040/Deutsche Forschungsgemeinschaft (DFG)
- FOR2599 (project P03 SCHR 1444/2-1)/Deutsche Forschungsgemeinschaft (DFG)
- TRR 374/1 2024 TP B07 (project number 509149993)/Deutsche Forschungsgemeinschaft (DFG)
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous